Volume 1, Issue 7: Role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 1, Issue 7)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to:
- Describe appropriate patients for GLP-1 agonist therapy.
- Explain how GLP-1 agonists can be used effectively in place of or along with basal insulin.
- Discuss how current data do not support concerns about the pancreatic safety of GLP-1 agonists.
Rajesh Garg, MD
Assistant Professor of Medicine
Harvard Medical School
Associate Physician, Division of Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
- 1.00 ANCC